Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0620920230550050987
Experimental & Molecular Medicine
2023 Volume.55 No. 5 p.987 ~ p.998
An MRTF-A?ZEB1?IRF9 axis contributes to fibroblast?myofibroblast transition and renal fibrosis
Qianwen Zhao

Tinghui Shao
Yuwen Zhu
Gengjie Zong
Junjie Zhang
Shifan Tang
Yanshan Lin
Hongzhen Ma
Zhifan Jiang
Yong Xu
Minh-Tung Do
Tao Zhang
Abstract
Myofibroblasts, characterized by the expression of the matricellular protein periostin (Postn), mediate the profibrogenic response during tissue repair and remodeling. Previous studies have demonstrated that systemic deficiency in myocardin-related transcription factor A (MRTF-A) attenuates renal fibrosis in mice. In the present study, we investigated the myofibroblast-specific role of MRTF-A in renal fibrosis and the underlying mechanism. We report that myofibroblast-specific deletion of MRTF-A, achieved through crossbreeding Mrtfa-flox mice with Postn-CreERT2 mice, led to amelioration of renal fibrosis. RNA-seq identified zinc finger E-Box binding homeobox 1 (Zeb1) as a downstream target of MRTF-A in renal fibroblasts. MRTF-A interacts with TEA domain transcription factor 1 (TEAD1) to bind to the Zeb1 promoter and activate Zeb1 transcription. Zeb1 knockdown retarded the fibroblast?myofibroblast transition (FMyT) in vitro and dampened renal fibrosis in mice. Transcriptomic assays showed that Zeb1 might contribute to FMyT by repressing the transcription of interferon regulatory factor 9 (IRF9). IRF9 knockdown overcame the effect of Zeb1 depletion and promoted FMyT, whereas IRF9 overexpression antagonized TGF-¥â-induced FMyT. In conclusion, our data unveil a novel MRTF-A?Zeb1?IRF9 axis that can potentially contribute to fibroblast?myofibroblast transition and renal fibrosis. Screening for small-molecule compounds that target this axis may yield therapeutic options for the mollification of renal fibrosis.
KEYWORD
Kidney diseases, Pathogenesis, Transcription
FullTexts / Linksout information
Listed journal information